Malaria prophylaxis in the traveler

被引:1
作者
Capdevila, J. A. [1 ]
Icart, R. [2 ]
机构
[1] Hosp Mataro, Med Interna Serv, Barcelona, Spain
[2] Univ Autonoma Barcelona, Dept Med, E-08193 Barcelona, Spain
来源
REVISTA CLINICA ESPANOLA | 2010年 / 210卷 / 02期
关键词
Malaria; Previention; Antimalaria drugs;
D O I
10.1016/j.rce.2009.06.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Malaria is a preventable and curable disease. The risk zones are those tropical and subtropical regions of the countries with endemic malaria. These countries are visited by 125 million international tourists yearly and it is estimated that up to 30,000 fait sick with malaria. Prevention is done by: preventing transmission (using mosquito repellent, mosquito nets, etc.) and by preventing the disease by chemoprophylaxis. The tatter aims to reduce the risk of suffering severe malaria, basically that produced by P. falciparum. It consists in the administration of antimalaria drugs before, during and after the trip. The choice of antimalaria drug will depend on the individual factors (allergies, contra-indications, etc.) and mainly on the resistance of P falciparum to these drugs. In areas with sensitivity to chloroquine, this should be the drug of choice and in those with resistances, three drugs have been recommended by both the CDC and WHO: Atovaquone/proguanil, Doxycycline and Mefloquine (C) 2009 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:77 / 83
页数:7
相关论文
共 50 条
  • [21] Organization of prophylaxis, diagnosis and treatment for malaria in France
    Bouchaud, O
    [J]. MEDECINE ET MALADIES INFECTIEUSES, 1999, 29 : 286S - 294S
  • [22] Compliance with Primary Malaria Chemoprophylaxis: Is Weekly Prophylaxis Better Than Daily Prophylaxis?
    Rodrigo, Chaturaka
    Rajapakse, Senaka
    Fernando, Sumadhya Deepika
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2020, 14 : 2215 - 2223
  • [23] Antimalarial Prophylaxis in Travelers to Malaria Risk Areas
    Vlckova, Jana
    Rupes, Vaclav
    Prokes, Zdenek
    Kollarova, Helena
    Horakova, Dagmar
    [J]. EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE, 2013, 62 (01): : 33 - 39
  • [24] A case of co-infection with malaria and chikungunya in a returning traveler from Nigeria
    Gaviria, Rafael Ruiz
    Santhekadur, Prashanth
    [J]. JOURNAL OF VECTOR BORNE DISEASES, 2021, 58 (02) : 178 - 180
  • [25] False positive malaria rapid diagnostic test in returning traveler with typhoid fever
    Meatherall, Bonnie
    Preston, Keith
    Pillai, Dylan R.
    [J]. BMC INFECTIOUS DISEASES, 2014, 14
  • [26] False positive malaria rapid diagnostic test in returning traveler with typhoid fever
    Bonnie Meatherall
    Keith Preston
    Dylan R Pillai
    [J]. BMC Infectious Diseases, 14
  • [27] Interest of malaria prophylaxis after surgical intervention in areas endemic for malaria, Niamey, Niger
    Djibo, A
    Madougou, B
    Bougarel, J
    Chippaux, JP
    [J]. BULLETIN DE LA SOCIETE DE PATHOLOGIE EXOTIQUE, 2001, 94 (03): : 258 - 259
  • [28] Pharmacovigilance of long-term malaria prophylaxis with mefloquine
    Moutaouakkil, Youssef
    el Jaoudi, Rachid
    Adouani, Badr
    Tadlaoui, Yasmina
    Serragui, Samira
    el Cadi, Mina Ait
    Cherrah, Yahia
    Lamsaouri, Jamal
    Bousliman, Yassir
    [J]. TOXICOLOGIE ANALYTIQUE ET CLINIQUE, 2019, 31 (01) : 30 - 36
  • [29] CHLOROQUINE IN MALARIA - ISNT IT TIME FOR REVISION OF PROPHYLAXIS SCHEDULES
    FRISK, M
    GUNNERT, G
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 44 (03) : 271 - 274
  • [30] Tafenoquine for malaria prophylaxis in adults: An integrated safety analysis
    Novitt-Moreno, Anne
    Ransom, Janet
    Dow, Geoffrey
    Smith, Bryan
    Read, Lisa Thomas
    Toovey, Stephen
    [J]. TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2017, 17 : 19 - 27